Connor, Clark & Lunn Investment Management (CC&L)’s Zimmer Biomet ZBH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-54,474
| Closed | -$5.91M | – | 1680 |
|
|
2024
Q2 | $5.91M | Sell |
54,474
-11,397
| -17% | -$1.24M | 0.02% | 392 |
|
|
2024
Q1 | $8.69M | Sell |
65,871
-1,780
| -3% | -$235K | 0.04% | 317 |
|
|
2023
Q4 | $8.23M | Buy |
67,651
+48,112
| +246% | +$5.86M | 0.04% | 312 |
|
|
2023
Q3 | $2.19M | Buy |
19,539
+560
| +3% | +$62.8K | 0.01% | 596 |
|
|
2023
Q2 | $2.76M | Buy |
+18,979
| New | +$2.76M | 0.01% | 524 |
|
|
2022
Q4 | – | Sell |
-4,349
| Closed | -$455K | – | 1454 |
|
|
2022
Q3 | $455K | Buy |
+4,349
| New | +$455K | ﹤0.01% | 832 |
|
|
2022
Q2 | – | Sell |
-9,748
| Closed | -$1.25M | – | 1220 |
|
|
2022
Q1 | $1.25M | Buy |
+9,748
| New | +$1.25M | 0.01% | 618 |
|
|
2021
Q3 | – | Sell |
-11,052
| Closed | -$1.73M | – | 1243 |
|
|
2021
Q2 | $1.73M | Buy |
+11,052
| New | +$1.73M | 0.01% | 576 |
|
|
2020
Q4 | – | Sell |
-7,246
| Closed | -$958K | – | 1062 |
|
|
2020
Q3 | $958K | Buy |
+7,246
| New | +$958K | 0.01% | 632 |
|
|
2019
Q3 | – | Sell |
-8,369
| Closed | -$957K | – | 1107 |
|
|
2019
Q2 | $957K | Buy |
+8,369
| New | +$957K | 0.01% | 577 |
|
|
2015
Q2 | – | Sell |
-6,901
| Closed | -$787K | – | 670 |
|
|
2015
Q1 | $787K | Sell |
6,901
-721
| -9% | -$82.2K | 0.01% | 342 |
|
|
2014
Q4 | $839K | Buy |
+7,622
| New | +$839K | 0.01% | 328 |
|